DJIA 16,058.35 -469.68 -2.84%
NASDAQ 4,636.11 -140.40 -2.94%
S&P 500 1,913.85 -58.33 -2.96%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Teva Announces U.S. Availability of ZECUITY® (sumatriptan iontophoretic transdermal system), First a

Teva Announces U.S. Availability of ZECUITY® (sumatriptan iontophoretic transdermal system), First and Only Transdermal Patch System for the Acute Treatment of Migraine

How The Bank Of Israel Got Its Last Rate Decision Wrong

Interesting TEVA Put And Call Options For October 9th

Eli Lilly's Alimta Patent Upheld by U.S. District Court

3 Stocks Pulling The Drugs Industry Downward

Short Sellers Have Mixed Feelings on Major Pharma

Acorda (ACOR) Gets Favorable Outcome in Ampyra IPR Issue

Mylan Confirms USPTO Institutes Inter Partes Review Proceedings vs Two Copaxone 40 mg/mL Dosing Pate

Mylan Confirms USPTO Institutes Inter Partes Review Proceedings vs Two Copaxone 40 mg/mL Dosing Patents

Teva's Phase III Rejig Leaves Some Unanswered Questions

Teva's Acquisition Program A Winner

See More Articles...